Kee Song Bio-Technology Holdings Limited announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was TWD 804.024 million compared to TWD 706.378 million a year ago. Operating income was TWD 17.721 million compared to operating loss of TWD 60.677 million a year ago. Net loss was TWD 6.528 million compared to TWD 125.322 million a year ago. Basic loss per share was TWD 0.18 compared to TWD 3.4 a year ago. For the nine months, sales was TWD 2,285.538 million compared to TWD 2,116.036 million a year ago. Operating loss was TWD 62.338 million compared to TWD 35.833 million a year ago. Net loss was TWD 64.599 million compared to TWD 117.055 million a year ago. Basic loss per share was TWD 1.75 compared to TWD 3.18 a year ago.